Works matching AU Kamaraju, Sailaja


Results: 29
    1

    National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 531, doi. 10.1007/s10549-025-07750-2
    By:
    • Cohen, Lauren N.;
    • Rogers, Christine C.;
    • Lloren, Jan Irene C.;
    • Kamaraju, Sailaja;
    • Chaudhary, Lubna N.;
    • Huang, Chiang-Ching;
    • Cobb, Adrienne N.;
    • Singh, Puneet;
    • Kong, Amanda L.;
    • Teshome, Mediget;
    • Cortina, Chandler S.
    Publication type:
    Article
    2
    3
    4
    5

    Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer.

    Published in:
    Endocrinology, 2021, v. 162, n. 8, p. 1, doi. 10.1210/endocr/bqab060
    By:
    • Kamaraju, Sailaja;
    • Fowler, Amy M;
    • Weil, Elizabeth;
    • Wisinski, Kari B;
    • Truong, Thu H;
    • Lehr, Martin;
    • Chaudhary, Lubna N;
    • Cheng, Yee Chung;
    • Chitambar, Christopher R;
    • Rui, Hallgeir;
    • Yee, Douglas;
    • Lange, Carol
    Publication type:
    Article
    6
    7
    8
    9
    10

    Amniotic band syndrome: A clinical brief.

    Published in:
    Journal of Dr. NTR University of Health Sciences, 2017, v. 6, n. 2, p. 121, doi. 10.4103/2277-8632.208005
    By:
    • Malireddy, Dasaradha Ramireddy;
    • Sailaja, Kamaraju;
    • Thomas, Suresh;
    • Mula, Moulika
    Publication type:
    Article
    11
    12
    13

    Equitable community-based participatory research engagement with communities of color drives All of Us Wisconsin genomic research priorities.

    Published in:
    Journal of the American Medical Informatics Association, 2024, v. 31, n. 12, p. 2940, doi. 10.1093/jamia/ocae265
    By:
    • Thareja, Suma K;
    • Yang, Xin;
    • Upama, Paramita Basak;
    • Abdullah, Aziz;
    • Torres, Shary Pérez;
    • Cocroft, Linda Jackson;
    • Bubolz, Michael;
    • McGaughey, Kari;
    • Lou, Xuelin;
    • Kamaraju, Sailaja;
    • Ahamed, Sheikh Iqbal;
    • Madiraju, Praveen;
    • Kwitek, Anne E;
    • Whittle, Jeffrey;
    • Franco, Zeno
    Publication type:
    Article
    14
    15

    A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer.

    Published in:
    Clinical Breast Cancer, 2025, v. 25, n. 3, p. 251, doi. 10.1016/j.clbc.2024.11.019
    By:
    • Kamaraju, Sailaja;
    • Fowler, Amy M.;
    • Tarima, Sergey;
    • Chaudhary, Lubna N.;
    • Burkard, Mark E.;
    • Giever, Thomas;
    • Cheng, Yee C.;
    • Parkes, Amanda;
    • Lange, Carol A.;
    • Pipp-Dahm, Michele;
    • Hegeman, Robert;
    • Siddiqui, Nauman;
    • Stella, Amy;
    • Rajguru, Saurabh;
    • Twaroski, Kyleigh;
    • Zurbriggen, Luke;
    • Jorns, Julie M.;
    • Rui, Hallgeir;
    • Keigley, Quinton J.;
    • Perlman, Scott B.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.

    Published in:
    Breast Cancer Research & Treatment, 2023, v. 201, n. 3, p. 387, doi. 10.1007/s10549-023-07038-3
    By:
    • Chaudhary, Lubna N.;
    • Jorns, Julie M.;
    • Sun, Yunguang;
    • Cheng, Yee Chung;
    • Kamaraju, Sailaja;
    • Burfeind, John;
    • Gonyo, Mary Beth;
    • Kong, Amanda L.;
    • Patten, Caitlin;
    • Yen, Tina;
    • Cortina, Chandler S.;
    • Carson, Ebony;
    • Johnson, Nedra;
    • Bergom, Carmen;
    • Tsaih, Shirng-Wern;
    • Banerjee, Anjishnu;
    • Wang, Yu;
    • Chervoneva, Inna;
    • Weil, Elizabeth;
    • Chitambar, Christopher R.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29